Events

Recall of Normal G-6-DPH Control

According to L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), this recall involved a device in France that was produced by Trinity Biotech.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Date
    2013-04-22
  • Event Country
    France
  • Event Source
    ANSM
  • Event Source URL
    https://ansm.sante.fr/S-informer/Informations-de-securite-Retraits-de-lots-et-de-produits/controle-g-6-dph-normal-trinity-biotech-rappel
  • Notes / Alerts
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • Extra notes in the data
  • Action
    ANSM has been informed of the implementation of a recall made by Trinity Biotech. The users concerned have received the attached mail (22/04/2013) (99 KB). This information is addressed to the directors of the health establishments, local correspondents of reactovigilance, medical biologists.

Device

Normal G-6-DPH Control
  • Model / Serial
  • Product Description
    in-vitro_medical_device
  • Manufacturer
    Trinity Biotech

Manufacturer

Trinity Biotech